vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Mistras Group, Inc. (MG). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $181.5M, roughly 1.0× Mistras Group, Inc.). Mistras Group, Inc. runs the higher net margin — 2.1% vs 0.9%, a 1.2% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 5.1%). Mistras Group, Inc. produced more free cash flow last quarter ($26.0M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -0.8%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Mistras Group, Inc. is a global provider of asset integrity and protection solutions, offering non-destructive testing, inspection, real-time monitoring, and engineering consulting services. Its key client segments include oil and gas, aerospace, power generation, and manufacturing industries, with operations spanning North America, Europe, and Asia-Pacific, helping clients enhance operational safety, extend asset lifespans, and minimize unplanned downtime.
FOLD vs MG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $181.5M |
| Net Profit | $1.7M | $3.8M |
| Gross Margin | 85.7% | 28.4% |
| Operating Margin | 8.6% | 7.0% |
| Net Margin | 0.9% | 2.1% |
| Revenue YoY | 23.7% | 5.1% |
| Net Profit YoY | -88.5% | -27.4% |
| EPS (diluted) | $0.00 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $181.5M | ||
| Q3 25 | $169.1M | $195.5M | ||
| Q2 25 | $154.7M | $185.4M | ||
| Q1 25 | $125.2M | $161.6M | ||
| Q4 24 | $149.7M | $172.7M | ||
| Q3 24 | $141.5M | $182.7M | ||
| Q2 24 | $126.7M | $189.8M | ||
| Q1 24 | $110.4M | $184.4M |
| Q4 25 | $1.7M | $3.8M | ||
| Q3 25 | $17.3M | $13.1M | ||
| Q2 25 | $-24.4M | $3.0M | ||
| Q1 25 | $-21.7M | $-3.2M | ||
| Q4 24 | $14.7M | $5.2M | ||
| Q3 24 | $-6.7M | $6.4M | ||
| Q2 24 | $-15.7M | $6.4M | ||
| Q1 24 | $-48.4M | $995.0K |
| Q4 25 | 85.7% | 28.4% | ||
| Q3 25 | 88.5% | 29.8% | ||
| Q2 25 | 90.2% | 29.1% | ||
| Q1 25 | 90.7% | 25.3% | ||
| Q4 24 | 90.1% | 26.5% | ||
| Q3 24 | 90.6% | 26.8% | ||
| Q2 24 | 91.1% | 27.1% | ||
| Q1 24 | 87.7% | 25.0% |
| Q4 25 | 8.6% | 7.0% | ||
| Q3 25 | 20.3% | 10.4% | ||
| Q2 25 | -6.1% | 4.5% | ||
| Q1 25 | -6.3% | -0.6% | ||
| Q4 24 | 10.7% | 6.1% | ||
| Q3 24 | 15.3% | 6.5% | ||
| Q2 24 | 11.8% | 6.3% | ||
| Q1 24 | -25.1% | 3.0% |
| Q4 25 | 0.9% | 2.1% | ||
| Q3 25 | 10.2% | 6.7% | ||
| Q2 25 | -15.8% | 1.6% | ||
| Q1 25 | -17.3% | -2.0% | ||
| Q4 24 | 9.8% | 3.0% | ||
| Q3 24 | -4.8% | 3.5% | ||
| Q2 24 | -12.4% | 3.4% | ||
| Q1 24 | -43.9% | 0.5% |
| Q4 25 | $0.00 | $0.12 | ||
| Q3 25 | $0.06 | $0.41 | ||
| Q2 25 | $-0.08 | $0.10 | ||
| Q1 25 | $-0.07 | $-0.10 | ||
| Q4 24 | $0.05 | $0.17 | ||
| Q3 24 | $-0.02 | $0.20 | ||
| Q2 24 | $-0.05 | $0.20 | ||
| Q1 24 | $-0.16 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $28.0M |
| Total DebtLower is stronger | $392.7M | $178.0M |
| Stockholders' EquityBook value | $274.2M | $235.1M |
| Total Assets | $949.9M | $578.8M |
| Debt / EquityLower = less leverage | 1.43× | 0.76× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $28.0M | ||
| Q3 25 | $263.8M | $27.8M | ||
| Q2 25 | $231.0M | $20.0M | ||
| Q1 25 | $250.6M | $18.5M | ||
| Q4 24 | $249.9M | $18.3M | ||
| Q3 24 | $249.8M | $20.4M | ||
| Q2 24 | $260.1M | $17.2M | ||
| Q1 24 | $239.6M | $16.9M |
| Q4 25 | $392.7M | $178.0M | ||
| Q3 25 | $392.0M | $202.3M | ||
| Q2 25 | $391.3M | $189.4M | ||
| Q1 25 | $390.7M | $171.9M | ||
| Q4 24 | $390.1M | $169.6M | ||
| Q3 24 | $389.5M | $189.7M | ||
| Q2 24 | $388.9M | $199.7M | ||
| Q1 24 | $388.4M | $198.4M |
| Q4 25 | $274.2M | $235.1M | ||
| Q3 25 | $230.4M | $227.4M | ||
| Q2 25 | $204.3M | $215.8M | ||
| Q1 25 | $193.6M | $198.7M | ||
| Q4 24 | $194.0M | $198.6M | ||
| Q3 24 | $178.8M | $205.2M | ||
| Q2 24 | $132.5M | $193.2M | ||
| Q1 24 | $130.7M | $187.1M |
| Q4 25 | $949.9M | $578.8M | ||
| Q3 25 | $868.8M | $596.3M | ||
| Q2 25 | $815.3M | $571.0M | ||
| Q1 25 | $789.8M | $526.8M | ||
| Q4 24 | $785.0M | $523.0M | ||
| Q3 24 | $786.6M | $551.7M | ||
| Q2 24 | $749.5M | $548.1M | ||
| Q1 24 | $721.8M | $542.1M |
| Q4 25 | 1.43× | 0.76× | ||
| Q3 25 | 1.70× | 0.89× | ||
| Q2 25 | 1.92× | 0.88× | ||
| Q1 25 | 2.02× | 0.87× | ||
| Q4 24 | 2.01× | 0.85× | ||
| Q3 24 | 2.18× | 0.92× | ||
| Q2 24 | 2.93× | 1.03× | ||
| Q1 24 | 2.97× | 1.06× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $32.1M |
| Free Cash FlowOCF − Capex | $16.0M | $26.0M |
| FCF MarginFCF / Revenue | 8.6% | 14.3% |
| Capex IntensityCapex / Revenue | 0.2% | 3.4% |
| Cash ConversionOCF / Net Profit | 9.62× | 8.55× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $8.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $32.1M | ||
| Q3 25 | $35.7M | $4.5M | ||
| Q2 25 | $-26.5M | $-9.3M | ||
| Q1 25 | $7.8M | $5.6M | ||
| Q4 24 | $-3.9M | $25.7M | ||
| Q3 24 | $-23.0M | $19.4M | ||
| Q2 24 | $22.7M | $4.5M | ||
| Q1 24 | $-29.7M | $604.0K |
| Q4 25 | $16.0M | $26.0M | ||
| Q3 25 | $35.3M | $-4.1M | ||
| Q2 25 | $-28.9M | $-14.7M | ||
| Q1 25 | $7.5M | $1.1M | ||
| Q4 24 | $-4.2M | $22.1M | ||
| Q3 24 | $-23.3M | $14.6M | ||
| Q2 24 | $21.6M | $-284.0K | ||
| Q1 24 | $-31.5M | $-4.2M |
| Q4 25 | 8.6% | 14.3% | ||
| Q3 25 | 20.9% | -2.1% | ||
| Q2 25 | -18.7% | -7.9% | ||
| Q1 25 | 6.0% | 0.7% | ||
| Q4 24 | -2.8% | 12.8% | ||
| Q3 24 | -16.5% | 8.0% | ||
| Q2 24 | 17.0% | -0.1% | ||
| Q1 24 | -28.5% | -2.3% |
| Q4 25 | 0.2% | 3.4% | ||
| Q3 25 | 0.2% | 4.4% | ||
| Q2 25 | 1.6% | 2.9% | ||
| Q1 25 | 0.2% | 2.8% | ||
| Q4 24 | 0.2% | 2.1% | ||
| Q3 24 | 0.3% | 2.6% | ||
| Q2 24 | 0.9% | 2.5% | ||
| Q1 24 | 1.6% | 2.6% |
| Q4 25 | 9.62× | 8.55× | ||
| Q3 25 | 2.06× | 0.34× | ||
| Q2 25 | — | -3.07× | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | 4.96× | ||
| Q3 24 | — | 3.02× | ||
| Q2 24 | — | 0.71× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
MG
Segment breakdown not available.
